nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0822	0.132	CcSEcCtD
Pyridostigmine—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0564	0.0909	CcSEcCtD
Pyridostigmine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.0425	0.0685	CcSEcCtD
Pyridostigmine—ACHE—Acetylcholine Synthesis—CHAT—amyotrophic lateral sclerosis	0.032	0.1	CbGpPWpGaD
Pyridostigmine—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0304	0.497	CbGeAlD
Pyridostigmine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0303	0.0488	CcSEcCtD
Pyridostigmine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0278	0.0448	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.0239	0.0385	CcSEcCtD
Pyridostigmine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0217	0.035	CcSEcCtD
Pyridostigmine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0207	0.0334	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0308	CcSEcCtD
Pyridostigmine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0303	CcSEcCtD
Pyridostigmine—ACHE—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0174	0.0546	CbGpPWpGaD
Pyridostigmine—ACHE—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0159	0.05	CbGpPWpGaD
Pyridostigmine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0239	CcSEcCtD
Pyridostigmine—ACHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.0144	0.0452	CbGpPWpGaD
Pyridostigmine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0218	CcSEcCtD
Pyridostigmine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0217	CcSEcCtD
Pyridostigmine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0209	CcSEcCtD
Pyridostigmine—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.0128	0.0403	CbGpPWpGaD
Pyridostigmine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0124	0.02	CcSEcCtD
Pyridostigmine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0182	CcSEcCtD
Pyridostigmine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.011	0.0177	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0173	CcSEcCtD
Pyridostigmine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0153	CcSEcCtD
Pyridostigmine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00924	0.0149	CcSEcCtD
Pyridostigmine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0145	CcSEcCtD
Pyridostigmine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0139	CcSEcCtD
Pyridostigmine—ACHE—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00845	0.0266	CbGpPWpGaD
Pyridostigmine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0136	CcSEcCtD
Pyridostigmine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0133	CcSEcCtD
Pyridostigmine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00813	0.0131	CcSEcCtD
Pyridostigmine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00798	0.0129	CcSEcCtD
Pyridostigmine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00772	0.0124	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0119	CcSEcCtD
Pyridostigmine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0115	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0112	CcSEcCtD
Pyridostigmine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0111	CcSEcCtD
Pyridostigmine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0068	0.011	CcSEcCtD
Pyridostigmine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00631	0.0102	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00626	0.0101	CcSEcCtD
Pyridostigmine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0098	CcSEcCtD
Pyridostigmine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00975	CcSEcCtD
Pyridostigmine—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00603	0.0189	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00567	0.0178	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00909	CcSEcCtD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00557	0.0175	CbGpPWpGaD
Pyridostigmine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00885	CcSEcCtD
Pyridostigmine—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00538	0.0169	CbGpPWpGaD
Pyridostigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00528	0.0166	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00844	CcSEcCtD
Pyridostigmine—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00506	0.0159	CbGpPWpGaD
Pyridostigmine—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00497	0.0156	CbGpPWpGaD
Pyridostigmine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00784	CcSEcCtD
Pyridostigmine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00777	CcSEcCtD
Pyridostigmine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00482	0.00777	CcSEcCtD
Pyridostigmine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00772	CcSEcCtD
Pyridostigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00471	0.0148	CbGpPWpGaD
Pyridostigmine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.00462	0.0756	CbGeAlD
Pyridostigmine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00732	CcSEcCtD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00422	0.0133	CbGpPWpGaD
Pyridostigmine—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00417	0.0131	CbGpPWpGaD
Pyridostigmine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00412	0.0674	CbGeAlD
Pyridostigmine—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00389	0.0122	CbGpPWpGaD
Pyridostigmine—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00376	0.0118	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00352	0.0111	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00347	0.0109	CbGpPWpGaD
Pyridostigmine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00327	0.0534	CbGeAlD
Pyridostigmine—BCHE—brainstem—amyotrophic lateral sclerosis	0.00325	0.0533	CbGeAlD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00306	0.00963	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00294	0.00925	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00289	0.00907	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00287	0.00903	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00266	0.00837	CbGpPWpGaD
Pyridostigmine—ACHE—brain—amyotrophic lateral sclerosis	0.00265	0.0434	CbGeAlD
Pyridostigmine—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00263	0.00826	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.0026	0.00818	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00258	0.0081	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00257	0.00809	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00238	0.00747	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00235	0.0074	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00232	0.0073	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0023	0.00722	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00228	0.00718	CbGpPWpGaD
Pyridostigmine—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00227	0.0371	CbGeAlD
Pyridostigmine—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00221	0.00695	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00219	0.00688	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00219	0.00688	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0021	0.0066	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00209	0.00656	CbGpPWpGaD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00208	0.00655	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00204	0.00642	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00204	0.0064	CbGpPWpGaD
Pyridostigmine—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00202	0.0331	CbGeAlD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00198	0.00621	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00197	0.0062	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00197	0.0062	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00197	0.0062	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00195	0.00614	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00195	0.00614	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00195	0.00613	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00194	0.0061	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00192	0.00602	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00186	0.00585	CbGpPWpGaD
Pyridostigmine—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00186	0.00584	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00183	0.00574	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00182	0.00572	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.0018	0.00567	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.0018	0.00567	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0018	0.00567	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00176	0.00553	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00176	0.00553	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00174	0.00547	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00173	0.00544	CbGpPWpGaD
Pyridostigmine—BCHE—nervous system—amyotrophic lateral sclerosis	0.00171	0.0279	CbGeAlD
Pyridostigmine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00168	0.00527	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00168	0.00527	CbGpPWpGaD
Pyridostigmine—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00164	0.0269	CbGeAlD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00163	0.00512	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00161	0.00506	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00161	0.00506	CbGpPWpGaD
Pyridostigmine—BCHE—cerebellum—amyotrophic lateral sclerosis	0.0016	0.0263	CbGeAlD
Pyridostigmine—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0015	0.0047	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0015	0.0047	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.0015	0.0047	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00149	0.0047	CbGpPWpGaD
Pyridostigmine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00146	0.00458	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00145	0.00457	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00139	0.00438	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00133	0.00419	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.00419	CbGpPWpGaD
Pyridostigmine—BCHE—brain—amyotrophic lateral sclerosis	0.0013	0.0213	CbGeAlD
Pyridostigmine—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.0013	0.00408	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0013	0.00408	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00125	0.00393	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00123	0.00387	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00117	0.00369	CbGpPWpGaD
Pyridostigmine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00115	0.0188	CbGeAlD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00112	0.00352	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00112	0.00351	CbGpPWpGaD
Pyridostigmine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00111	0.0181	CbGeAlD
Pyridostigmine—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.0011	0.00345	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00104	0.00326	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00102	0.0032	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00102	0.0032	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000948	0.00298	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00093	0.00292	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000925	0.00291	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000907	0.00285	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000907	0.00285	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000881	0.00277	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000865	0.00272	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000846	0.00266	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00083	0.00261	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000813	0.00255	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000795	0.0025	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000786	0.00247	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000771	0.00242	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000762	0.0024	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000735	0.00231	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000725	0.00228	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000656	0.00206	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000651	0.00205	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000632	0.00199	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000587	0.00184	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000581	0.00182	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000557	0.00175	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000514	0.00162	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000498	0.00156	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000497	0.00156	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000468	0.00147	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000459	0.00144	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000422	0.00133	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000418	0.00131	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000385	0.00121	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000377	0.00118	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000376	0.00118	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000356	0.00112	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000351	0.0011	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000344	0.00108	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000275	0.000864	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000273	0.000857	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000273	0.000857	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000264	0.00083	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000249	0.000784	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000245	0.000771	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000235	0.00074	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000232	0.000729	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000227	0.000713	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000218	0.000685	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000209	0.000655	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000202	0.000636	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000197	0.00062	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000186	0.000585	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000172	0.000539	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000153	0.000481	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000149	0.00047	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000138	0.000433	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000118	0.000369	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000113	0.000356	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000105	0.00033	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.09e-05	0.000191	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.59e-05	0.000176	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	4.6e-05	0.000145	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.15e-05	9.91e-05	CbGpPWpGaD
